![]() |
|
|
Vol. 303, Issue 2, 476-486, November 2002
Department of Pharmacology (L.H.L., D.A.P., L.H.M.) and Experimental and Clinical Therapeutics Program (L.H.M.), Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan
| |
Abstract |
|---|
|
|
|---|
The dicarboxylate carrier (DCC) is one of two carriers responsible for glutathione (GSH) transport into rat kidney mitochondria. The central hypothesis of the present study was that overexpression of this carrier in renal proximal tubular cells increases content of mitochondrial GSH, which in turn can protect these cells from chemical-induced injury. We first cloned the carrier protein and verified its properties. This was accomplished by reverse transcribing total rat kidney RNA and polymerase chain reaction amplification with primers based on the complete cDNA sequence for the mitochondrial DCC protein. DCC was expressed as a His6-tagged protein, purified from Escherichia coli inclusion bodies, and reconstituted into proteoliposomes for transport assays. Time- and concentration-dependent uptake of both L-[3H-glycyl]GSH and [2-14C]malonate was observed with kinetics, substrate specificity, and inhibitor sensitivities similar to those observed in rat kidney proximal tubules. We next transiently transfected NRK-52E cells with the cDNA for rat kidney DCC to overexpress the protein. The presence of the recombinant DCC-His6 protein was confirmed by immunoblots. Transport of both GSH and malonate into the mitochondrial fraction of transfected cells was enhanced 2.45- to 11.3-fold, compared with that in wild-type cells. Transfected cells exhibited markedly less apoptosis from tert-butyl hydroperoxide or S-(1,2-dichlorovinyl)-L-cysteine than did wild-type cells, validating the central hypothesis and providing us with a valuable and novel tool with which to further study GSH and thiol redox status in renal mitochondria, and the function of GSH transport in regulation of processes such as apoptosis and oxidative phosphorylation.
| |
Introduction |
|---|
|
|
|---|
The
tripeptide GSH plays numerous critical roles in mammalian cells,
including maintenance and regulation of cellular thiol and redox status
and serving as a substrate in various xenobiotic metabolism reactions
(Reed, 1990
). Within renal proximal tubular cells, there are at least
two major pools of GSH, one in the cytoplasm and one in the
mitochondrial matrix (Schnellmann et al., 1988
). Cellular fractionation
studies showed that the mitochondrial pool in rabbit and rat renal
proximal tubule comprises approximately 15 to 30% of total cellular
GSH (Schnellmann et al., 1988
; Lash et al., 1998
), which equates with
the approximate volume fraction of mitochondria in the proximal
tubules. GSH is the predominant nonprotein thiol in mitochondria, and
its presence in this organelle at millimolar levels is necessary to
maintain redox status, and hence activity of numerous
sulfhydryl-dependent processes (Beatrice et al., 1984
; Yagi and Hatefi,
1984
; Lê-Quôc and Lê-Quôc, 1985
, 1989
).
Accordingly, selective depletion of the mitochondrial pool of GSH has
been associated with enhanced susceptibility to several types of
chemical-induced toxicity, such as oxidative stress (Martensson and
Meister, 1989
; Reed, 1990
; Shan et al., 1993
; Fernandez-Checa et al.,
1997
). Furthermore, decreased concentrations of mitochondrial GSH are
associated with
S-(1,2-dichlorovinyl)-L-cysteine (DCVC)-induced acute toxicity (Lash and Anders, 1987
) and apoptosis (Chen et al., 2001
) in renal mitochondria and renal proximal tubular cells, respectively; apoptosis in general (Kroemer et al., 1998
); and
chronic ethanol exposure and alcoholic liver disease in liver mitochondria (Fernandez-Checa et al., 1991
, 1993
, 1997
).
The predominant, if not exclusive, localization of enzymes catalyzing
de novo synthesis of GSH is the cytoplasm (Griffith and Meister, 1985
;
Lash et al., 1998
), indicating that transport of the intact tripeptide
from the cytoplasm across the mitochondrial inner membrane must occur
to supply the mitochondria with its pool of GSH. GSH does not diffuse
passively across the mitochondrial inner membrane. Rather, because
mitochondria possess a membrane potential with the matrix space
negative relative to the cytoplasm and because GSH is a negatively
charged molecule at physiological pH, GSH must be transported actively
or in exchange for another anion (Smith et al., 1996
).
Eight known anion carriers are present on the mitochondrial inner
membrane that could conceivably play a role in the mitochondrial uptake
of GSH from the cytoplasm. In previous studies (McKernan et al., 1991
;
Chen and Lash, 1998
; Chen et al., 2000
), we examined the role of these
carriers by assessing substrate specificity and patterns of inhibition,
and determined that two carriers, the dicarboxylate carrier (DCC) and
the oxoglutarate carrier (OGC), are responsible for at least 80% of
the total uptake of cytoplasmic GSH into renal cortical mitochondria.
These two carriers, along with the mono- and tricarboxylate carriers,
share a common 30-kDa molecular mass subunit and are believed to
belong to a carrier "superfamily" (Palmieri et al., 1996
). Function
of each of these carriers is electroneutral, catalyzing the exchange of
anions across the inner membrane without any net transfer of charge.
Both the DCC and OGC proteins have been purified to homogeneity and
reconstituted into proteoliposomes (Bisaccia et al., 1985
, 1988
; Kaplan
and Pedersen, 1985
; Lançar-Benba et al., 1994
). Two difficulties
with studying the purified DCC protein from mammalian tissues relates
to its low abundance in the inner mitochondrial membrane and its
instability in its purified form, due to autoxidation and inactivation
(Kaplan and Pedersen, 1985
; Bisaccia et al., 1988
). To circumvent this
limitation, the cDNA for the DCC from Norway rat was isolated using
related expressed sequence tags homologous to genes in
Caenorhabditis elegans and yeast (Kakhniashvili et al.,
1997
). The rat DCC was then expressed in Escherichia coli and functionally reconstituted into proteoliposomes (Fiermonte et al.,
1998
).
In this communication, we significantly expand on this earlier report
(Fiermonte et al., 1998
) and our prior studies of GSH transport in
mitochondria from rat kidney proximal tubules (Chen and Lash, 1998
;
Lash et al., 1998
), by expressing recombinant rat DCC (as the
N-His6 fusion protein). By reconstituting
purified DCC into proteoliposomes and transiently expressing DCC in a
cell line derived from rat kidney proximal tubules (NRK-52E), we show that DCC transports GSH and malonate with properties similar to those
observed in intact rat kidney mitochondria. The recombinant DCC-His6 in transfected NRK-52E cells localizes
in mitochondria where it mediates GSH uptake, thereby demonstrating
function of the carrier in an intact renal cell. Furthermore,
overexpression of the DCC in NRK-52E cells markedly protected against
apoptosis induced by either DCVC or tert-butyl hydroperoxide
(tBH), suggesting the toxicological significance of the mitochondrial
GSH transport process.
| |
Materials and Methods |
|---|
|
|
|---|
Materials.
[3H-glycyl]GSH (44.8 Ci/mmol) was purchased from PerkinElmer Life Sciences (Boston,
MA). [2-14C]Malonate (56 mCi/mmol) was
purchased from ICN Pharmaceuticals (Costa Mesa, CA).
-Glutamyl amino
acids, S-alkyl GSH derivatives, and ophthalmic acid were
purchased from Sigma-Aldrich (St. Louis, MO), Bachem California
(Torrance, CA), or Roche Applied Science (Indianapolis, IN).
Restriction enzymes for PCR, other enzymes (e.g., DNA polymerases and
T7 RNA polymerase), and plasmids were purchased from New England
Biolabs (Beverly, MA), Promega (Madison, WI), and Invitrogen (Carlsbad,
CA). PCR primers were custom synthesized by Integrated DNA Technology,
Inc. (Coralville, IA). Cloning vectors (pGEM-T Easy, pRSET, and
pcDNA3.1/V5-His-TOPO) were purchased from Promega and Invitrogen.
Dowex-1, Triton X-100, Percoll, and phospholipids were purchased from
Sigma-Aldrich. Materials for gel electrophoresis (SDS, acrylamide,
agarose, and buffers) were purchased from Bio-Rad (Hercules, CA) or
Sigma-Aldrich. ProBond nickel-chelating resin was purchased from
Invitrogen. Millicell polycarbonate filter inserts (0.4-µm pore size,
25 mm in diameter) were purchased from Millipore Corporation (Bedford,
MA). NRK-52E cells (catalog number CRL-1571), cell culture medium
(catalog number 30-2002; Dulbecco's modified Eagle's medium with 4 mM
L-glutamine adjusted to contain 1.5 g/l sodium
bicarbonate, 4.5 g/l glucose, and 1.0 mM sodium pyruvate), and 10%
(w/v) bovine calf serum were purchased from American Type Culture
Collection (Manassas, VA). Antibodies to the His6
fusion proteins were purchased from Invitrogen. Double-distilled,
deionized water was used for all experiments. All other chemicals and
reagents were purchased from commercial vendors and were of the highest
purity available.
Amplification of Rat Kidney Mitochondrial DCC cDNA by reverse
transcription-PCR and Bacterial Expression.
Total RNA was
previously isolated from renal cortical homogenates of male Fischer-344
rats (200-300 g b.wt.; Charles River Laboratories, Inc., Wilmington,
MA) by acid phenol extraction using the TRIzol extraction kit
(Invitrogen) and was stored at
80°C until needed. Total rat kidney
RNA was reverse transcribed with Superscript II reverse transcriptase
and amplified with forward and reverse primers based on the complete
cDNA sequence (1946 base pairs) for the mitochondrial DCC protein from
the Norway rat (Rattus norvegicus; GenBank accession number
AJ223355). PCR primers were 5'-CGG GCC AGG TCG CTG CTG CTC T-3' (sense,
positions 8-29) and 5'-GCC AAG GCA GGG TCG GAA GGC GTA G-3'
(antisense, positions 1039-1063), where the coding region is from
positions 34 to 894; PCR conditions were 30 cycles of 94°C × 3 min for denaturation and 68°C × 2 min for annealing/extension.
The 1056-base pair product was ligated into a T-A cloning vector
(pGEM-T Easy) for transformation. Confirmation of the PCR product was
by automated DNA sequencing.
Preparation of Proteoliposomes for Reconstitution of Purified
DCC.
Liposomes and proteoliposomes were prepared essentially as
described previously (Chen et al., 2000
). Briefly, liposomes were prepared by transferring 700 mg of phosphatidylcholine into a 30-ml
polypropylene tube and drying under a stream of nitrogen. After
redissolving the dried lipid in diethyl ether and removal of solvent
under nitrogen, liposome buffer (7 ml; 120 mM HEPES, 50 mM KCl, and 1 mM EDTA, pH 7.0) was added to the dried lipid, the tube was flushed
with nitrogen, sealed, and vigorously mixed on a vortex mixer. Lipid
was then dispersed in a bath sonicator for approximately 60 min and was
stored at
80°C for up to 3 months. Proteoliposomes were prepared by
mixing purified carrier protein (200 µl, 50 µg of protein) or
liposome buffer (for a blank control) with 0.5 ml of liposomes and 50 µl of substrate solution (buffer containing 20 mM phosphate and 20 mM
malate) in a final volume of 1 ml. After mixing on a vortex mixer, the
proteoliposomes were rapidly frozen in liquid nitrogen and stored at
80°C for up to 1 month until use. Immediately before assay, the
proteoliposome suspension was thawed, sonicated with a bath sonicator
at room temperature, placed on ice for 1 min, and then passed through an anion exchange column (Dowex-1, 100-200 mesh, equilibrated with
liposome buffer and prepared in a 9-inch Pasteur pipette) to remove
external substrate by elution with liposome buffer. The opalescent
fraction (approximately 1 ml) contains the proteoliposomes and was
collected. The proteoliposomes were equilibrated at room temperature
for approximately 5 min before being used in transport assays. This
freeze-thaw cycle and sonication method give rise to a heterogeneous
population of large, primarily unilamellar proteoliposomes that are
suitable for transport studies (Kaplan and Pedersen, 1985
).
Transport Assays in Reconstituted Proteoliposomes. Transport of substrates (i.e., GSH and malonate) into proteoliposomes was measured by first preincubating 200 µl of proteoliposomes (preloaded with 1 mM phosphate and 1 mM malate) for 1 min with 12 µl of "reconstitution buffer" (120 mM HEPES, 50 mM KCl, and 1 mM EDTA, pH 7.4). Competitive inhibitors were added simultaneously with substrates. Transport was initiated by addition of 12 µl of 20× radiolabeled substrate. At various times (30-240 s), 30-µl aliquots were transferred to a microcentrifuge tube containing 70 µl of reconstitution buffer + 40 mM of an irreversible transport inhibitor (i.e., pyridoxal 5'-phosphate), and tubes were mixed and placed on ice until the next processing step. After completion of time courses, samples were loaded onto Sephacryl S-100 mini-columns, which were prepared in 5.75-inch Pasteur pipettes. These columns were placed in 16 × 125-mm glass test tubes and were centrifuged at 2300 rpm × 2 min in a tabletop clinical centrifuge. Supernatant from each tube was transferred into a 5-ml scintillation vial, and each tube was washed with 200 µl of scintillation fluid, which was then added to scintillation vials.
Uptake rate was calculated by linear curve fitting as described previously (Chen and Lash, 1998
Pt)] versus time according to
Halestrap (1975)Culture of NRK-52E Cells. NRK-52E cells were cultured on collagen-coated, polystyrene T-25 or T-175 culture flasks with Dulbecco's modified Eagle's medium containing 4% (w/v) glutamine, 1.5 g/l sodium bicarbonate, 4.5 g of glucose/l, 1 mM sodium pyruvate, and 10% (v/v) bovine calf serum in an atmosphere of 5% CO2/95% air at 37°C. On reaching confluence (5-9 days), subcultures were prepared by a 15-min treatment with 0.02% (w/v) EDTA, 0.05% (w/v) trypsin solution and replating the cells at a density of 4 × 104 cells/cm2.
Transfection of NRK-52E Cells. NRK-52E cells were transiently transfected with rat kidney DCC cDNA to overexpress mitochondrial GSH transport activity. Plasmid DNA was purified following amplification in E. coli cells, using the Promega Wizard Prep purification kit. cDNA encoding the rat kidney DCC was subcloned into the pcDNA3.1/V5-His-TOPO vector and transfected into the NRK-52E cells by either the calcium phosphate method (Current Protocols in Molecular Biology, 1999) or with FuGENE 6 from Roche Applied Science. For the calcium phosphate method, purified plasmid containing 200 mM CaCl2 in HEPES buffer, pH 7.4, was added dropwise to subconfluent T-175 flasks to a final concentration of 20 µg/10 ml of Dulbecco's modified Eagle's medium. After 24 h, medium was removed and the cells were washed twice with phosphate-buffered saline (PBS). After 48 h, cells were harvested by incubating with Cellstripper (Mediatech, Herndon, VA) for 5 min and gentle scraping. These harvested cells were then used for isolation of mitochondria for transport measurements and Western blot analyses (see below). For the FuGENE 6 method, transient transfections were carried out as described by the manufacturer using a 3:1 ratio of FuGENE 6 reagent to plasmid DNA. After 24 h, cells were harvested as described above.
Isolation of Mitochondria from NRK-52E Cells and Transport
Measurements.
Mitochondria were prepared from seven confluent
T-175 flasks, which contain approximately 70 to 85 × 106 NRK-52E cells, by differential centrifugation
as described previously (McKernan et al., 1991
). Yield of mitochondrial
protein was 6 to 10.5 mg. Purity of mitochondria was determined by
measurement of activities of marker enzymes for mitochondria (succinate
dehydrogenase and glutamate dehydrogenase), plasma membrane (alkaline
phosphatase, (Na+ + K+)-stimulated ATPase), cytoplasm (lactate
dehydrogenase), and endoplasmic reticulum (glucose 6-phosphatase) in
whole cells and the mitochondrial fraction. Most of the total cellular
activity of the mitochondrial marker enzymes (
75%) was recovered in
the mitochondrial fraction, whereas minimal-to-modest amounts of total
cellular activity of markers for the other subcellular organelles were
recovered in this fraction. Specifically, approximately 5% of total
cellular activity of markers for the plasma membrane and endoplasmic
reticulum and <2% of total activity of the cytoplasmic marker enzyme
were recovered in the mitochondrial fraction. This indicates that the mitochondrial fraction obtained from the NRK-52E cells is of high purity and has minimal contamination with other subcellular organelles.
SDS-Polyacrylamide Gel Electrophoresis and Western Blotting.
For gel electrophoresis, 10 or 20 µg of protein was loaded per well
onto a 10% (w/v) or a 12% (w/v) polyacrylamide gel (Bio-Rad), and
separation was achieved according to the method of Laemmli (1970)
.
Total protein was visualized by staining with Coomassie Brilliant Blue
G. For Western blot analysis, protein was transferred by
electroblotting to a nitrocellulose membrane (MSI, Westborough, MA),
blocked with 3% (w/v) bovine serum albumin (Promega), washed with
Tris-buffered saline containing Tween 20, probed with a monoclonal anti-RGSHHHH tag antibody (QIAGEN, Valencia, CA), washed with Tris-buffered saline containing Tween 20, and then probed with an
anti-mouse IgG antibody conjugated to alkaline phosphatase (Jackson
Immunoresearch Laboratories, West Grove, PA). Immunoreactive bands were
visualized after incubation with a solution containing 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium (Promega).
Flow Cytometry Analysis of Cell Cycle and Quantitation of Apoptosis. Cell cultures were washed twice with sample buffer (PBS plus 1 g of glucose/l filtered through a 0.22-µm filter), dislodged by trypsin/EDTA incubation, centrifuged at 400g × 10 min at 22°C, and resuspended in sample buffer. Cell concentrations were adjusted to 1 to 3 × 106 cells/ml with sample buffer and 1 ml of the cell suspension was centrifuged at 400g × 10 min at 22°C. All of the supernatant except 0.1 ml/106 cells was removed and the remaining cells were mixed on a vortex mixer in the remaining fluid for 10 s. Next, 1 ml of ice-cold ethanol (70%, v/v) was added to the sample in a dropwise manner, with samples being mixed for 10 s between drops. Tubes were capped and fixed in ethanol at 4°C. After fixation, cells were stained with propidium iodide (50 µg/ml) containing RNase A (100 U/ml). Samples were then mixed, centrifuged at 1000g × 5 min at 22°C, and all the ethanol except 0.1 ml was removed. Cells were mixed in the residual ethanol and 1 ml of the propidium iodide staining solution was added to each tube. After mixing again, cells were incubated at room temperature for at least 30 min. Samples were analyzed within 24 h by flow cytometry using an FACSCalibur flow cytometer (BD Biosciences, San Jose, CA), which is a core facility of the National Institute of Environmental Health Sciences Center for Molecular Toxicology with Human Applications at Wayne State University. Analyses were performed with 20,000 events per sample using the ModFit LT version 2 for Macintosh data acquisition software package (Verity Software House, Inc., Topsham, ME; distributed by BD Immunocytochemistry System BDIS). Propidium iodide was detected by the FL-2 photomultiplier tube. Fractions of apoptotic cells were quantified by analysis of the sub-G1 (subdiploid) peak with ModFit cell cycle analysis. The percentages of distribution of cells in the various stages of the cell cycle (G0/G1, S, and G2/M) were also calculated. Cell aggregates were discarded in the flow cytometry analysis by postfixation aggregate discrimination.
Data Analysis. Data were normalized to protein content, which was determined by the bicinchoninic acid protein assay from Pierce Chemical (Rockford, IL). All measurements were performed three to five times. Significant differences between means were first assessed by a one-way or two-way analysis of variance, depending on the comparisons being tested. When significant "F values" were obtained, the Fisher's protected least significant difference t test was performed to determine which means were significantly different from one another, using a two-tail probability, P < 0.05, as the criteria for significance.
| |
Results |
|---|
|
|
|---|
Bacterial Expression of the Rat Kidney Mitochondrial DCC.
The
full-length cDNA for the rat DCC was prepared from rat kidney total RNA
by RT-PCR. The cDNA was subcloned into the pRSET-B expression vector
for expression of DCC protein as an N-terminal His6 fusion protein. Expression of DCC in one
clone (15) was readily induced with IPTG (Fig.
1A); the arrow shows the time-dependent increase in expression of a 35.5-kDa protein, the expected molecular mass of the DCC-His6 product. This was
confirmed by Western analysis (Fig. 1B). Figure 1A also shows that
DCC-His6 could be solubilized from inclusion
bodies. The detergent-solubilized extract from inclusion bodies was
fractionated on a Ni2+-affinity column. The
purified DCC-His6 was approximately 90% pure by
Coomassie staining (Fig. 2). The overall
yield of DCC-His6 from a 1-liter culture of
bacteria was typically 20 to 25 mg of protein.
|
|
Reconstitution of Recombinant Rat Kidney DCC-His6
Protein.
The partially purified DCC fraction was reconstituted
into proteoliposomes to assess its transport activity with GSH and
dicarboxylate substrates. Time courses for the uptake of GSH (0.05-10
mM; Fig. 3, A and B) and malonate
(0.01-5 mM; Fig. 3, C and D) were determined in phosphate- and
malate-containing proteoliposomes. In preloaded proteoliposomes,
transport exhibited a characteristic spike, reflecting a heteroexchange
of the trans- for cis-substrates. Thereafter, intravesicular radioactive substrate modestly decreased. Reconstituted DCC exhibited time- and concentration-dependent uptake of both GSH and
malonate. For both substrates at nearly all concentrations tested,
maximal intravesicular content of transported substrate was achieved by
2 min. Initial rates (after 2 min) and maximal intravesicular contents
of malonate were approximately 5- to 6-fold higher than those for GSH.
|
|
-glutamyl-L-glutamate (McKernan et al.,
1991
|
|
Mitochondrial GSH Transport Activity in Transfected NRK-52E
Cells.
To better explore the role of the DCC in GSH transport in
an intact renal cell and to develop a strategy to increase
mitochondrial GSH levels and protect cells from various forms of
chemical-induced injury, NRK-52E cells were transiently transfected
with the cDNA for the rat kidney mitochondrial DCC in
pcDNA3.1/V5-His-TOPO. Mitochondrial fractions were prepared from three
clones and were tested for the presence of the
DCC-His6 fusion protein by immunoblot analysis
with antibody directed to the His6 tag (Fig.
5). Whereas no reactivity was detected in
the wild-type cells, a single, prominent band at approximately 35.5 kDa
was detected in mitochondrial extracts from each of the three clones,
indicating expression of the recombinant protein. The relative
expression of the recombinant protein varied 1.72-fold, as judged by
densitometry.
|
|
Influence of Overexpression of rDCC-His6 on Sensitivity
to Chemical-Induced Apoptosis.
The influence of overexpression of
the DCC protein on sensitivity of the NRK-52E cells to chemical-induced
apoptosis was next examined. Both wild-type cells (NRK-52E-WT) and
transfectants overexpressing rDCC-His6
(NRK-52E-rDCC+) were incubated with 1 mM GSH for 24 h, followed by
incubation for 1, 2, or 4 h without treatment, or with tBH (10 or
50 µM) or DCVC (50 or 200 µM), in the presence of 20 µM GSH. The
20 µM GSH was chosen to mimic the concentration of GSH in the
extracellular or periplasmic space and is that to which renal cells are
normally exposed (Lash and Jones, 1985
).
|
|
|
| |
Discussion |
|---|
|
|
|---|
Mitochondrial GSH status is a critical determinant of cellular energetics and function and plays a key role in determining susceptibility of cells to various forms of chemical or pathological injury. The ability to manipulate GSH status in this organelle can provide a greater understanding of precisely how mitochondrial GSH functions in various processes, including oxidative phosphorylation and apoptosis, but also a tool with which to modulate cellular injury upon exposure to various toxicants. The present communication describes one such approach in which one of the major mechanisms by which cells compartmentalize GSH is genetically altered to produce protection from two model toxicants.
Over the past several years, we have been studying the transport of GSH
into renal proximal tubular mitochondria (McKernan et al., 1991
; Chen
and Lash, 1998
; Chen et al., 2000
). Transport of GSH from the cytoplasm
into the mitochondrial matrix is the primary, if not sole, source of
GSH for this subcellular compartment because of the absence of
significant synthesis of GSH from its precursors within the
mitochondrial matrix (Griffith and Meister, 1985
; McKernan et al.,
1991
; Smith et al., 1996
). Two electroneutral anion carriers, the DCC
and OGC, were identified as being responsible for most, if not all, of
the transport of GSH into renal cortical mitochondria (Chen and Lash,
1998
; Chen et al., 2000
). This conclusion was based on examination of
substrate specificity and inhibitor studies. Although a partially
purified preparation of mitochondrial anion carriers was reconstituted
and used by others to study the transport of various dicarboxylates
(Kaplan and Pedersen, 1985
; Saint-Macary and Foucher, 1985
; Bisaccia et
al., 1988
) and by us to study GSH transport (Chen et al., 2000
), there
are inherent problems or limitations with this experimental approach.
First, the carrier proteins are present in the mitochondrial inner
membrane at relatively low abundance, making it difficult to obtain
sufficient amounts of material for experimentation. Second, of the
various anion carriers of the inner membrane, the DCC protein, in
particular, is relatively unstable in a purified form
(Lançar-Benba et al., 1994
), making it difficult to obtain
sufficient amounts of pure protein suitable for functional assays or
protein chemistry. The availability of the complete cDNA sequence from
the rat (Fiermonte et al., 1998
) affords us the opportunity to express
the DCC protein in relatively large amounts, to study its catalytic
function in greater detail and manipulate its molecular regulation to
probe its physiological and toxicological function.
We showed previously that GSH transport into renal cortical
mitochondria was insensitive to membrane potential (McKernan et al.,
1991
; Chen and Lash, 1998
), which is consistent with the function of
the electroneutral DCC and OGC. This suggests that GSH is transported
by these carriers as a dianion. As discussed previously (Chen and Lash,
1998
), the relatively alkaline pH of the mitochondrial matrix and the
suggested presence of a microenvironment near the active site of the
carrier proteins effectively lowers the
pKa of the thiol group so that a
larger proportion of GSH molecules may be in the thiolate form.
In the present study, we expressed the full-length DCC cDNA from rat
kidney mitochondria in bacteria as an N-terminal
His6 fusion protein to facilitate its isolation
and detection with His6-specific antibodies. DCC
synthesis was induced with IPTG in a time-dependent manner and was
extracted from inclusion bodies for fractionation on a
Ni2+-Sepharose affinity column. Our results
demonstrate that the partially purified DCC-His6,
reconstituted in lipid membranes, was functional. Function was shown by
measurements of time and concentration dependence of GSH and malonate
uptake. As we found in isolated mitochondria from rat kidneys (Chen and
Lash, 1998
) and in the enriched and reconstituted anion carrier
preparation (Chen et al., 2000
), transport of both substrates exhibits
Michaelis-Menten kinetics and the rate of uptake and maximal
accumulation of malonate are at least 5-fold greater than those for
GSH. Nonetheless, the kinetics of GSH uptake calculated from the
reconstituted, bacterially expressed DCC protein are reasonable
compared with those observed previously in other in vitro model
systems. The shape of the time courses for uptake of GSH and malonate
(Fig. 3), which exhibited maxima at 2-min time points and slight
decreases thereafter, is consistent with that which we and others
typically observe in artificial proteoliposome vesicles in which the
transport process under investigation involves an exchange of
substrates on opposite sides of the membrane; the slight overshoot is
likely due to trans-stimulation of uptake.
Sensitivity of GSH and malonate uptake to various competitive and
noncompetitive inhibitors provided additional evidence that recombinant
DCC-His6 was functionally identical to the
protein detected in partially purified preparations from rat or rabbit kidney. This includes inhibition by butylmalonate, pyridoxal
5'-phosphate, and mercurials. Furthermore, GSH inhibited malonate
uptake. With respect to the specificity of GSH uptake,
-glutamyl
amino acids and ophthalmic acid were good inhibitors, consistent with
the properties we described previously for GSH transport into renal cortical mitochondria (McKernan et al., 1991
; Chen and Lash, 1998
). The
properties that apply to dicarboxylate transport are also comparable
with those previously reported in the literature (Bisaccia et al.,
1985
, 1988
; Saint-Macary and Foucher, 1985
; Kaplan and Pedersen, 1985
;
Fiermonte et al., 1993
, 1998
; Lançar-Benba et al., 1994
; Kaplan
et al., 1995
; Iacobazzi et al., 1996
; Palmieri et al., 1996
;
Kakhniashvili et al., 1997
).
An important goal for the present study was to establish transport
function upon transfection of the His-tagged DCC construct into an
intact renal cell line, NRK-52E cells, derived from normal rat kidney
proximal tubules. Unlike some other commonly used renal epithelial cell
lines, basic cellular energetics and redox status in NRK-52E cells have
not been characterized extensively. In a separate study (Lash et al.,
2002
), we provided baseline data on mitochondrial function and GSH
transport and metabolism. With the exception of very low activity of
brush-border membrane enzymes, including
-glutamyltransferase, GSH
metabolism and plasma membrane transport in NRK-52E cells were
comparable with what are commonly observed in freshly isolated or
primary cultures or rat renal proximal tubular cells. Notably, the
NRK-52E cells have a low content of mitochondria, as judged by use of a
mitochondria-specific fluorescent dye and confocal microscopy, and low
activities of several mitochondrial dehydrogenases, of oxidative
phosphorylation, and of GSH and malonate transport across the inner
membrane, compared with those in freshly isolated or primary cultures
of rat renal proximal tubular cells. This finding is certainly not
uncommon in an immortalized, epithelial cell line. This
"deficiency" in the NRK-52E cells in comparison with the in vivo
renal proximal tubule may actually facilitate our studies because
extracellular degradation of GSH, which can cause experimental
artifacts in transport studies, is minimal in these cells.
Immunoblot analysis using an antibody directed against the C-terminal
His6 tag of our expressed protein confirmed
successful transfection of the NRK-52E cells. More importantly,
mitochondria isolated from transfectants exhibited significantly
increased rates of uptake and higher maximal accumulation of both GSH
and malonate than in those isolated from wild-type cells. The amount of
stimulation of substrate uptake seemed to approximately correlate with
the level of expression of the recombinant protein in the transfected
NRK-52E cells. These observations were carried further by demonstrating
that transfectants exhibited much less apoptosis compared with
wild-type cells when incubated with tBH or DCVC, which are both
oxidants and mitochondrial toxicants (Lash and Anders, 1987
; Hagen et
al., 1988
; Lash and Tokarz, 1990
; McKernan et al., 1991
; Lash et al.,
2002
). Hence, overexpression of the DCC from rat kidney in a stable
cell line derived from rat proximal tubule provides marked protection
from oxidant-induced apoptosis. This experimental approach allows us to
manipulate the mitochondrial thiol/disulfide redox and GSH status,
thereby providing a novel tool with which to probe mitochondrial
function and modulate cellular susceptibility to oxidants and other
mitochondrial toxicants.
In summary, although we have confirmed that the bacterially expressed and reconstituted DCC protein exhibits identical function for transport of GSH and dicarboxylates as determined previously, the novelty of the present results is that we demonstrate function of a cloned and bacterially expressed mitochondrial transporter with GSH, which provides the framework for studies on the molecular regulation of and more controlled manipulation of mitochondrial GSH status. Furthermore, we show that NRK-52E cells exhibited increased rates of mitochondrial uptake of GSH and dicarboxylates when these cells are transiently transfected to overexpress the DCC protein and that these cells are relatively resistant to chemical-induced apoptosis.
| |
Footnotes |
|---|
Accepted for publication July 9, 2002.
Received for publication June 11, 2002.
This work was funded by National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK40725 (to L.H.L. and L.H.M.). Core facilities funded by the National Institute of Environmental Health Sciences Center for Molecular Toxicology with Human Applications (Grant P30-ES06639) at Wayne State University were used for some of these studies.
DOI: 10.1124/jpet.102.040220
Address correspondence to: Dr. Lawrence H. Lash, Department of Pharmacology, Wayne State University School of Medicine, 540 East Canfield Ave., Detroit, MI 48201. E-mail: l.h.lash{at}wayne.edu
| |
Abbreviations |
|---|
GSH, glutathione;
DCVC, S-(1,2-dichlorovinyl)-L-cysteine;
DCC, dicarboxylate carrier;
OGC, oxoglutarate carrier;
NRK, normal rat
kidney;
tBH, tert-butyl hydroperoxide;
PCR, polymerase
chain reaction;
PBS, phosphate-buffered saline;
FACS, fluorescence-activated cell sorting;
IPTG, isopropyl
-D-thiogalactoside.
| |
References |
|---|
|
|
|---|
-oxoglutarate carrier from pig heart mitochondria.
Biochim Biophys Acta
810:
362-369[Medline].This article has been cited by other articles:
![]() |
E. Arystarkhova, C. Donnet, A. Munoz-Matta, S. C. Specht, and K. J. Sweadner Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and {gamma}-subunit in response to stress Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1179 - C1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Velsor, C. Kariya, R. Kachadourian, and B. J. Day Mitochondrial Oxidative Stress in the Lungs of Cystic Fibrosis Transmembrane Conductance Regulator Protein Mutant Mice Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 579 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. G. van de Poll, C. H. C. Dejong, and P. B. Soeters Adequate Range for Sulfur-Containing Amino Acids and Biomarkers for Their Excess: Lessons from Enteral and Parenteral Nutrition J. Nutr., June 1, 2006; 136(6): 1694S - 1700S. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xu, D. A. Putt, L. H. Matherly, and L. H. Lash Modulation of Expression of Rat Mitochondrial 2-Oxoglutarate Carrier in NRK-52E Cells Alters Mitochondrial Transport and Accumulation of Glutathione and Susceptibility to Chemically Induced Apoptosis J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1175 - 1186. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||